FDX1 and bladder transitional cell carcinoma: However, in a few tumors (bladder urothelial carcinoma (BLCA), cholangiocarcinoma (CHOL), mesothelioma (MESO) and rectum adenocarcinoma (READ), FDX1 expression was not correlated with genomic instability.